RPRX, SCMM, CVAT Stock-PR.com Reporting 10/30/09

Stock-PR Reporting

FREE Daily Stock Alerts From Stock-PR.com

________________________________________

Repros Therapeutics (NasdaqGM:RPRX) today announced that the Company has entered into a settlement agreement with its major creditors for the large majority of the debt incurred associated with the recently suspended Proellex® clinical program.

SCM Microsystems, Inc. (Nasdaq: SCMM Prime Standard: SMY), a leading provider of solutions for secure access, secure identity and secure exchange, announced today that its stockholders have approved an increase of the amount of common shares authorized during yesterday's annual meeting of stockholders.

Cavitation Technologies, Inc. (CTI) (OTC Bulletin Board: CVAT - News; Berlin: WTC) is pleased to announce a 3-for-1 forward stock split effective 10/29/09 . CTI is a world leader in the development of technologies that represent a quantum leap over existing processing methods for a wide variety of applications and industries. Positioned to provide licensing and sales of its technology which can be applied to virtually every industrial fluid that requires complex molecular bonding, including large-scale water purification, removing impurities from agricultural based oils, biodiesel production, instant aging effects for alcoholic spirits, increased extraction of end product in crude oil refining, blending of bio-fuels as well as production of hydro-fuel (up to 15% water content yielding more efficient and cleaner burning) and much more.

________________________________________

________________________________________

******Advertisement******

********************************

Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has received five thousand shares of free trading stock from a third party for advertising services for Cavitation Technologies, Inc. (CVAT.OB) and an additional twenty-five thousand shares of 144 restricted stock from Cavitation Technologies, Inc. (CVAT.OB) for 12 months of advertisement services.